Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2024-05-28–present
Board Member
Anika Therapeutics, Inc. (ANIK)Equibles does not estimate personal net worth.
Get an email with a short summary when Anika Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ANIK alertsJoseph Capper is recorded as Board Member at Anika Therapeutics, Inc. (ANIK) since May 28, 2024. Anika Therapeutics, Inc. reported in an 8-K filed May 28, 2024 that Joseph Capper was appointed Class II director, effective May 28, 2024. Anika Therapeutics, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Anika Therapeutics, Inc. includes Cheryl Blanchard (CEO and Board Member), Stephen (Steve) Griffin (CEO and Board Member), Stephen D. Griffin (CEO, CFO and Board Member) and 7 others.
“and (ii) Mr. Capper to the Board as a Class II director, with a term expiring at the Company's 2025 annual meeting of stockholders.”
2024-05-28–present
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2024-05-28–present